Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Direct Current Stimulation (tDCS) an Adjuvant to Intensive Speech Therapy in Chronic Post Stroke Aphasia

NCT02801864 is registered in ClinicalTrials.gov with Austin Speech Labs as lead sponsor.

NCT NCT02801864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02801864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Direct Current Stimulation (tDCS) an Adjuvant to Intensive Speech Therapy in Chronic Post Stroke Aphasia
Lead sponsor
Austin Speech Labs
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2016
Completion date
June 30, 2019
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia, language